Inventor
Yun Yen
Inventor
Arcadia, CA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds15%
C12NMicroorganisms or enzymes11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
C07CAcyclic or carbocyclic compounds6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C07HSugars2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
11,084,786Compounds and pharmaceutical composition associated with ubiquitination-proteasome system202110,745,433Compounds for inhibiting cancer and virus202010,745,350Compounds and pharmaceutical composition associated with ubiquitination-proteasome system202010,624,897Chlorobenzene substituted azaaryl compounds202010,577,328Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases202010,246,455Histone deacetylase inhibitors201910,201,530Treatment of BRCA1-defective cancer or resistant cancers201910,072,294Ultra-high sensitive monitoring of early transplantation failure20189,931,322Treatment of BRCA1-defective cancer or resistant cancers20189,810,684'Method for increasing number of stem cells in human or animal bodies'20179,770,473'Treatment of immunosuppression-related disorders'20179,029,089'Methods for predicting survival in cancer patients'20158,859,239'Methods for small RNA sequencing'20148,563,307'Treatment of immunosuppression-related disorders'20138,394,630'Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs)'20138,163,783'Ribonucleotide reductase inhibitors and methods of use'20127,956,076'Ribonucleotide reductase inhibitors and methods of use'20117,157,570'Human ribonucleotide reductase M2 subunit'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2018Patents assigned to YEN YUN (7)· patent assignee history
2007–2021Based in Arcadia, CA, US· patent location history
2011–2019Patents assigned to HOPE CITY (7)· patent assignee history
2015–2018Patents assigned to LIU QIANG (2)· patent assignee history
2017Based in Arcadin, CA, US· patent location history
2019–2020Patents assigned to UNIV TAIPEI MEDICAL (4)· patent assignee history
2020–2021Patents assigned to CALGENT BIOTECHNOLOGY CO LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOPE CITY | 7 | 2011–2019 |
| YEN YUNself | 7 | 2007–2018 |
| UNIV TAIPEI MEDICAL | 4 | 2019–2020 |
| CALGENT BIOTECHNOLOGY CO LTD | 2 | 2020–2021 |
| LIU QIANG | 2 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Arcadia, California, US | 16 | 2007–2021 |
| Arcadin, California, US | 2 | 2017 |